Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 9:14:1118848.
doi: 10.3389/fendo.2023.1118848. eCollection 2023.

Pharmacological approaches to the prevention of type 2 diabetes mellitus

Priyanka Majety  1 , Faustina Alejandra Lozada Orquera  1 , Dinesh Edem  2 , Osama Hamdy  3
Affiliations
Review

Pharmacological approaches to the prevention of type 2 diabetes mellitus

Priyanka Majety et al. Front Endocrinol (Lausanne). .

Abstract

About 1 in 10 adults worldwide are estimated to have diabetes mellitus. They are at risk of developing life-threatening complications resulting in reduced quality of life, increased mortality and higher healthcare costs. The ability to prevent or delay type 2 diabetes mellitus (T2DM) by modifying some of its risk factors has been hypothesized for decades. The long and often gradual time-course of increasing dysglycemia prior to diabetes diagnosis suggests that interventions during that period could be effective in preventing T2DM. In addition to lifestyle modifications, certain drugs prevent or slow development of hyperglycemia. Recently, drugs used for obesity management were shown to prevent T2DM. In this review, we discuss various pharmacotherapeutic options for preventing T2DM.

Keywords: metformin; pharmacotherapy; prediabetes; prevention; remission; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer GW declared a past collaboration with the author PM to the handling editor.

References

    1. Gassasse Z, Smith D, Finer S, Gallo V. Association between urbanisation and type 2 diabetes: an ecological study. BMJ Glob Health (2017) 2(4):e000473. doi: 10.1136/bmjgh-2017-000473 - DOI - PMC - PubMed
    1. Thanikachalam M, Fuller CH, Lane KJ, Sunderarajan J, Harivanzan V, Brugge D, et al. . Urban environment as an independent predictor of insulin resistance in a south Asian population. Int J Health Geogr (2019) 18(1):5. doi: 10.1186/s12942-019-0169-9 - DOI - PMC - PubMed
    1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract (2019) 157:107843. doi: 10.1016/j.diabres.2019.107843 - DOI - PubMed
    1. Holman N, Young B, Gadsby R. Current prevalence of type 1 and type 2 diabetes in adults and children in the UK. Diabetes Med (2015) 32(9):1119–20. doi: 10.1111/dme.12791 - DOI - PubMed
    1. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. . IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract (2018) 138:271–81. doi: 10.1016/j.diabres.2018.02.023 - DOI - PubMed

MeSH terms